The AHA's statement highlights that acute coronary syndrome occurs in premenopausal women, despite their historically perceived lower cardiovascular risk.
2
Younger women with acute coronary syndrome receive fewer guideline-directed therapies and experience worse outcomes compared to men.
3
Management of ACS in premenopausal women requires tailored approaches due to unique pathophysiological factors and lack of robust clinical trial data.
4
Barriers to timely diagnosis and treatment include symptom misattribution, implicit gender bias, and underuse of diagnostic tests.
5
Improved awareness, representation in research, and participation in cardiac rehabilitation are essential for better outcomes in young women with ACS.
